Table 2.
Log‐binomial regression analysis for predictors of hypertension among PWH prescribed ART
| Covariate | Unadjusted RR (95% CI) | p‐value for unadjusted RR | Adjusted RR (95% CI) | p‐value for adjusted RR |
|---|---|---|---|---|
| Age (years) | 1.05 (1.03 to 1.06) | <0.0001 | 1.04 (1.03 to 1.06) | <0.0001 |
| Sex (female) | 0.58 (0.41 to 0.82) | 0.002 | 0.83 (0.58 to 1.18) | 0.29 |
| HIV disease and treatment specifics | ||||
| Current CD4 (cells/μL) | ||||
| >500 | REF | 0.92 | ||
| 350 to 500 | 1.21 (0.80 to 1.83) | |||
| 200 to 349 | 1.17 (0.75 to 1.82) | |||
| 100 to 199 | 1.17 (0.56 to 2.46) | |||
| 50 to 99 | 1.17 (0.48 to 2.85) | |||
| <50 | 0.67 (0.11 to 4.18) | |||
| Nadir CD4 (cells/μL) | ||||
| >500 | REF | 0.39 | ||
| 350 to 500 | 2.02 (0.62 to 6.62) | |||
| 200 to 349 | 2.45 (0.82 to 7.36) | |||
| 100 to 199 | 2.17 (0.72 to 6.56) | |||
| 50 to 99 | 1.76 (0.53 to 5.88) | |||
| <50 | 1.54 (0.42 to 5.61) | |||
| Total time on ART (years) | ||||
| <2 | REF | 0.62 | ||
| 2 to 4 | 1.16 (0.70 to 1.91) | |||
| 4 to 6 | 0.96 (0.51 to 1.81) | |||
| >6 | 1.29 (0.82 to 2.03) | |||
| On PI‐based ART (yes) | 0.69 (0.38 to 1.25) | 0.22 | ||
| CVD risk factors | ||||
| Diabetes (yes) | 1.17 (0.61 to 2.27) | 0.63 | 0.91 (0.50 to 1.65) | 0.75 |
| Self‐reported tobacco use (yes) | 1.48 (1.00 to 2.19) | 0.052 | ||
ART, antiretroviral therapy; CI, confidence interval; CVD, cardiovascular disease; PI, protease inhibitor; RR, relative risk.